Scientific Sessions 2025  /  Genomic and Precision Medicine Symposium: Model Systems: Preclinical to Phase I Bridge: Session 3, The Evolving Landscape of Regulation  /  Gene editing, replacement, and regulation targeting for cardiomyopathies
Logo

American Heart Association

  68
  0

Final ID:

Gene editing, replacement, and regulation targeting for cardiomyopathies

  • Hinson, John  ( The Jackson Laboratory , Hartford , Connecticut , United States )
  • Rossano, Joseph  ( Children's Hospital of Philadelphia , Philadelphia , Pennsylvania , United States )
  • Olson, Eric  ( UNIV TEXAS SOUTHWESTERN MED CTR , Dallas , Texas , United States )
  • Mcnally, Elizabeth  ( NORTHWESTERN UNIVERSITY , Chicago , Illinois , United States )
    • Author Disclosures:
    John Hinson: DO have relevant financial relationships ; Research Funding (PI or named investigator):Lexeo Therapeutics:Past (completed) ; Advisor:Kate Therapeutics:Past (completed) ; Consultant:Avidity Biosciences:Past (completed) ; Advisor:Tevard Biosciences:Active (exists now) | Joseph Rossano: DO have relevant financial relationships ; Consultant:AskBIo:Active (exists now) ; Consultant:CRI Biotech:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Bristol Myers Squibb:Active (exists now) ; Consultant:Astellas:Active (exists now) | Eric Olson: DO NOT have relevant financial relationships | Elizabeth McNally: DO have relevant financial relationships ; Consultant:Tenaya Therapeutics:Past (completed) ; Other (please indicate in the box next to the company name):Novartis:Active (exists now) ; Consultant:PepGene:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Genomic and Precision Medicine Symposium: Model Systems: Preclinical to Phase I Bridge: Session 3, The Evolving Landscape of Regulation

Friday, 11/07/2025 , 04:00PM - 05:15PM

Cardiovascular Seminar

More abstracts on this topic:
Post-myocardial infarction fibrosis therapy: novel non-invasive approaches through the regulatory landscape

Radisic Milica, Ruiz-lozano Pilar

Actualization of the FDA Reauthorization Act 2.0 for genotype-specific cardiovascular therapeutics

Adler Eric, Teerlink John, Helms Adam

More abstracts from these authors:
Modeling dilated cardiomyopathy in animals, cells, and tissues

Kim Yuri, Backx Peter, Hinson John, Vunjak-novakovic Gordana

The basics of pediatric HCM: Who, what, when, where, why?

Rossano Joseph

You have to be authorized to contact abstract author. Please, Login
Not Available